| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |